FYERS
ZR2 Bioenergy142.00
-0.50 (-0.35%)

ZR2 Bioenergy Share Price

142.00-0.50 (-0.35%)
-63.94% past 1 Year

Corporate filings & documents

Announcements

This is to inform that the Board of Directors at its meeting held today i.e. Friday August 14 2026 inter-alia have considered and approved the following: 1. Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026. In this regard we enclose the following: i. Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026. ii. Limited Review Report of the Company for the quarter ended June 30 2026.
1 month ago
This is to inform that the Board of Directors at its meeting held today i.e. Friday August 14 2026 inter-alia have considered and approved the following: 1. Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026. In this regard we enclose the following: i. Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026. ii. Limited Review Report of the Company for the quarter ended June 30 2026.
1 month ago
BOARD MEETING OUTCOME FOR APPROVING AND CONSIDERATION OF THE UNAUDITED FINANCIAL YEAR ENDED 30TH JUNE 2026.
1 month ago
BOARD MEETING OUTCOME FOR APPROVING AND CONSIDERATION OF THE UNAUDITED FINANCIAL YEAR ENDED 30TH JUNE 2026.
1 month ago
Pursuant to Regulation 32 of the Securities and Exchange Board of India ("SEBI") (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations") read with Regulation 173A of SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 we have enclosed herewith the Monitoring Agency Report for the quarter ended June 30 2026 issued by Crisil Ratings Limited ("Monitoring Agency") in respect of the utilization of proceeds raised through Preferential Issue by the Company duly reviewed by the Audit Committee and taken on record by the Board of Directors.
1 month ago
Pursuant to Regulation 32 of the Securities and Exchange Board of India ("SEBI") (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations") read with Regulation 173A of SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 we have enclosed herewith the Monitoring Agency Report for the quarter ended June 30 2026 issued by Crisil Ratings Limited ("Monitoring Agency") in respect of the utilization of proceeds raised through Preferential Issue by the Company duly reviewed by the Audit Committee and taken on record by the Board of Directors.
1 month ago
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find enclosed herewith a confirmation certificate received from MUFG Intime India Private Limited the Registrar and Transfer Agent of the Company for quarter ended June 30 2026.
2 months ago
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find enclosed herewith a confirmation certificate received from MUFG Intime India Private Limited the Registrar and Transfer Agent of the Company for quarter ended June 30 2026.
2 months ago
We inform you that in accordance with the Companys Code of Conduct for Insider Trading (Code) read with applicable provisions of SEBI (PIT) Regulation 2015 the Trading Window for dealing in the shares of the Company will remain closed with effect from Wednesday July 01 2026 till 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results for quarter ended on June 30 2026.
3 months ago
We inform you that in accordance with the Companys Code of Conduct for Insider Trading (Code) read with applicable provisions of SEBI (PIT) Regulation 2015 the Trading Window for dealing in the shares of the Company will remain closed with effect from Wednesday July 01 2026 till 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results for quarter ended on June 30 2026.
3 months ago
This is to inform that the Board of Directors at its meeting held today i.e. Friday May 29 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2026.
3 months ago
This is to inform that the Board of Directors at its meeting held today i.e. Friday May 29 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2026.
3 months ago
This is to inform that the Board of Directors at its meeting held today i.e. Friday May 29 2026 inter-alia have considered and approved the following:1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2026.
3 months ago
This is to inform that the Board of Directors at its meeting held today i.e. Friday May 29 2026 inter-alia have considered and approved the following:1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2026.
3 months ago
The Exchange has sought clarification from ZR2 Bioenergy Limited with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
3 months ago
The Exchange has sought clarification from ZR2 Bioenergy Limited with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
3 months ago
ZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve In compliance with Regulation 29 and other applicable provisions of LODR Regulations this is to inform that 01/2026-27 meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31 2026
3 months ago
ZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve In compliance with Regulation 29 and other applicable provisions of LODR Regulations this is to inform that 01/2026-27 meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31 2026
3 months ago
MONITORING AGENCY REPORT FOR THE QUARTER ENDED 31ST MARCH 2026
4 months ago
MONITORING AGENCY REPORT FOR THE QUARTER ENDED 31ST MARCH 2026
4 months ago
Dear Sir/Madam We write to inform you that in accordance with the Companys Code of Conduct for Insider Trading (Code) read with applicable provisions of SEBI (Prohibition of Insider Trading) Regulation 2015 the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed with effect from April 01 2026 till 48 hours after the approval and dissemination of Audited Financial Results for the quarter and financial year ended March 31 2026 to the Stock Exchanges.
5 months ago
Dear Sir/Madam We write to inform you that in accordance with the Companys Code of Conduct for Insider Trading (Code) read with applicable provisions of SEBI (Prohibition of Insider Trading) Regulation 2015 the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed with effect from April 01 2026 till 48 hours after the approval and dissemination of Audited Financial Results for the quarter and financial year ended March 31 2026 to the Stock Exchanges.
5 months ago
Dear Sir/Madam Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find enclosed herewith a confirmation certificate received from MUFG Intime India Private Limited the Registrar and Transfer Agent of the Company for quarter ended March 31 2026. Please take the above on record.
5 months ago
Dear Sir/Madam Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find enclosed herewith a confirmation certificate received from MUFG Intime India Private Limited the Registrar and Transfer Agent of the Company for quarter ended March 31 2026. Please take the above on record.
5 months ago
The Exchange has sought clarification from ZR2 Bioenergy Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months ago
The Exchange has sought clarification from ZR2 Bioenergy Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months ago
The Exchange has sought clarification from ZR2 Bioenergy Ltd on March 17 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
6 months ago
This is in furtherance of the intimation given by the Company on May 10 2024 wherein we had informed you that the Company had allotted 2 59 22 000 convertible warrants of the Company on a Preferential Basis to Acquirer alias Proposed Promoter and Strategic Investors (Non-Promoters) for an issue price of Rs. 65/- each aggregating to the amount of Rs. 168 49 30 000/-. Thereafter out of which Rs. 42 12 32 500/- (Rupees Forty-Two Crores Twelve Lakhs Thirty-Two Thousand Five Hundred) has already been received as the initial subscription amount at the time of allotment of the warrants.
7 months ago
Allotment of 1 23 50 000 Additional Equity Shares (on account of conversion of Compulsorily Convertible Debentures (CCDs) into equity shares.
7 months ago
Allotment of 1 23 50 000 Additional Equity Shares (on account of conversion of Compulsorily Convertible Debentures (CCDs) into equity shares.
7 months ago
Monitoring Agency Report for the quarter ended December 31 2025 in respect of Funds raised by issuance of Convertible Warrants and Compulsory Convertible Debentures on a Preferential Basis
7 months ago
Monitoring Agency Report for the quarter ended December 31 2025 in respect of Funds raised by issuance of Convertible Warrants and Compulsory Convertible Debentures on a Preferential Basis
7 months ago
Outcome of Board Meeting held on February 14 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31 2025 as per SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
7 months ago
Outcome of Board Meeting held on February 14 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31 2025 as per SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
7 months ago
Outcome of Board Meeting held on February 14 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31 2025 as per SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
7 months ago
Outcome of Board Meeting held on February 14 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31 2025 as per SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
7 months ago
Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018
8 months ago
Intimation of Trading Window Closure
8 months ago
Resignation of Company Secretary & Compliance Officer
8 months ago
Submission of Newspaper Advertisement issued for the publication of Unaudited (Standalone and Consolidated) Financial Results for the quarter ended September 30 2025
10 months ago
Submission of Newspaper Advertisement issued for the publication of Unaudited (Standalone and Consolidated) Financial Results for the quarter ended September 30 2025
10 months ago
Monitoring Agency Report for the quarter ended September 30 2025
10 months ago
Publication of Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30 2025 along with Limited Review Report thereon
10 months ago
Outcome of the Board Meeting held on November 14 2025 to consider and approve un audited (Standalone and Consolidated) Financials of the Company for the quarter and half year ended September 30 2025
10 months ago
ZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve unaudited (standalone and consolidated) Financial Statement for the quarter ended September 30 2025
10 months ago
Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulation 2018 for the quarter ended September 30 2025
11 months ago
Appointment of Secretarial Auditor
11 months ago
Scrutinizers Report on voting at the 86th Annual General Meeting of the Company held on September 29 2025
11 months ago
Proceeding of 86th Annual General Meeting of the Company held on September 29 2025
11 months ago
Intimation of Trading Window Closure for the quarter ended September 30 2025
12 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

ZR2 Bioenergy Ltd Share Price Today

The ZR2 Bioenergy Ltd share price today is ₹119.55. During the trading session, the ZR2 Bioenergy Ltd share price opened at ₹119.55 and recorded an intraday high of ₹119.55 and a low of ₹119.55. Last closing price was ₹114.55. Over the past 52 weeks, the ZR2 Bioenergy Ltd share price has ranged between ₹90.00 and ₹419.20. The current ZR2 Bioenergy Ltd stock price reflects real-time market activity based on executed trades on the exchange.